Global gene expression profiling of renal scarring in a rat model of pyelonephritis

Pediatric Nephrology

Volumn 23, Issue 7, 2008, Pages 1059-1071

  Ichino, Manabu ^a,b   Mori, Terumi ^b   Kusaka, Mamoru ^a,b   Kuroyanagi, Yoko ^a   Ishikawa, Kiyohito ^a   Shiroki, Ryoichi ^a   Kowa, Hiroe ^b   Kurahashi, Hiroki ^b   Hoshinaga, Kiyotaka ^a,b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Biomarker; Expression profiling; Microarray; Renal scarring; Urinary tract infection; Vesicoureteral reflux

Indexed keywords

APOLIPOPROTEIN C1; BIOLOGICAL MARKER; CALGRANULIN B; CELL ADHESION MOLECULE; CHEMOKINE; COLLAGEN TYPE 1; COLLAGEN TYPE 15; COMPLEMENT COMPONENT C3; CYTOCHROME P450 1B1; CYTOKINE; GLYCOPROTEIN; IMMUNOGLOBULIN J CHAIN; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 3; KALININ; KHELLIN; MATRILYSIN; MATRIX PROTEIN; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOPONTIN; PROTEIN BCL 3; RAUWOLFIA ALKALOID; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE FUNCTION; HISTOPATHOLOGY; KIDNEY SCAR; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PYELONEPHRITIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; KIDNEY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PYELONEPHRITIS; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 44449162517     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0717-6     Document Type: Article

References (30)

1. International Reflux Study Committee (IRSC) (1981) Medical versus surgical treatment of primary vesicoureteral reflux: A prospective international reflux study in children. J Urol 125:277-283
2. Meguid El Nahas A, Bello AK (2005) Chronic kidney disease: The global challenge. Lancet 365:331-340
3. Liu Y (2006) Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 69:213-217
4. Eikmans M, Baelde HJ, de Heer E, Bruijn JA (2002) RNA expression profiling as prognostic tool in renal patients: Toward nephrogenomics. Kidney Int 62:1125-1135
5. Choi H, Oh SJ, So Y, Lee DS, Lee A, Kim KM (1999) No further development of renal scarring after antireflux surgery in children with primary vesicoureteral reflux: Review of the results of 99m technetium dimercapto-succinic acid renal scan. J Urol 162:1189-1192
6. Svanborg Edén C, Kulhavy R, Mñrild S, Prince SJ, Mestecky J (1985) Urinary immunoglobulins in healthy individuals and children with acute pyelonephritis. Scand J Immunol 21:305-313
7. Hedges S, Stenqvist K, Lidin-Janson G, Martinell J, Sandberg T, Svanborg C (1992) Comparison of urine and serum concentrations of interleukin-6 in women with acute pyelonephritis or asymptomatic bacteriuria. J Infect Dis 166:653-656
8. Agace WW, Hedges SR, Ceska M, Svanborg C (1993) Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest 92:780-785
9. Martins SM, Darlin DJ, Lad PM, Zimmern PE (1994) Interleukin-1B: A clinically relevant urinary marker. J Urol 151:1198-1201
10. Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, Paradies G, Caldarulo E, Infante B, Schena FP (2000) MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int 58:182-192
11. Gbadegesin RA, Cotton SA, Coupes BM, Awan A, Brenchley PE, Webb NJ (2002) Plasma and urinary soluble adhesion molecule expression is increased during first documented acute pyelonephritis. Arch Dis Child 86:218-221
12. Prat C, Domínguez J, Rodrigo C, Giménez M, Azuara M, Jiménez O, Galié N, Ausina V (2003) Elevated serum procalcitonin values correlate with renal scarring in children with urinary tract infection. Pediatr Infect Dis J 22:438-442
13. Hewitson TD, Wu HL, Becker GJ (1995) Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 15:411-417
14. Matsumoto T, Haraoka M, Mizunoe Y, Takahashi K, Kubo S, Sakumoto M, Tanaka M, Kumazawa J (1995) Preventive effect of ulinastatin on renal scarring in rat model of pyelonephritis induced by direct or ascending infection with Serratia marcescens or Escherichia coli. Nephron 69:65-70
15. Tullus K, Hörlin K, Svenson SB, Källenius G (1984) Epidemic outbreaks of acute pyelonephritis caused by nosocomial spread of P fimbriated Escherichia coli in children. J Infect Dis 150:728-736
16. Söderhäll M, Normark S, Ishikawa K, Karlsson K, Teneberg S, Winberg J, Möllby R (1997) Induction of protective immunity after Escherichia coli bladder infection. J Clin Invest 100:364-372
17. Hultgren SJ, Schwan WR, Schaeffer AJ, Duncan JL (1986) Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect Immun 54:613-620
18. Langermann S, Möllby R, Burlein JE, Palaszynski SR, Auguste CG, DeFusco A, Strouse R, Schenerman MA, Hultgren SJ, Pinkner JS, Winberg J, Guldevall L, Söderhäll M, Ishikawa K, Normark S, Koenig S (2000) Vaccination with fimH adhesion protect cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis 181:774-778
19. Takahashi K, Muratani T, Saito M, Matsumoto T (2001) Inflammatory mediators in urosepsis using rat urinary tract infection models. Hinyokigeka 14:643-646
20. Kusaka M, Kuroyanagi Y, Kowa H, Nagaoka K, Mori T, Yamada K, Shiroki R, Kurahashi H, Hoshinaga K (2007) Genomewide expression profiles of rat model renal isografts from brain dead donors. Transplantation 83:62-70
21. Hewitson TD, Darby IA, Bisucci T, Jones CL, Becker GJ (1998) Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring. J Am Soc Nephrol 9:632-642
22. Jahnukainen T, Chen M, Celsi G (2005) Mechanisms of renal damage owing to infection. Pediatr Nephrol 20:1043-1053
23. Mezzano SA, Droguett MA, Burgos ME, Ardiles LG, Aros CA, Caorsi I, Egido J (2000) Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int 57:147-158
24. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231-1238
25. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-1358
26. Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286-1292
27. Eikmans M, Baelde HJ, Hagen EC, Paul LC, Eilers PH, De Heer E, Bruijn JA (2003) Renal mRNA levels as prognostic tools in kidney diseases. J Am Soc Nephrol 14:899-907
28. Tullus K, Wang JA, Lu Y, Burman LG, Brauner A (1996) Interleukin-1 alpha and interleukin-6 in the urine, kidney, and bladder of mice inoculated with Escherichia coli. Pediatr Nephrol 10:453-457
29. Haraoka M, Senoh K, Ogata N, Furukawa M, Matsumoto T, Kumazawa J (1996) Elevated interleukin-8 levels in the urine of children with renal scarring and/or vesicoureteral reflux. J Urol 155:678-680
30. Haraoka M, Matsumoto T, Takahashi K, Kubo S, Tanaka M, Kumazawa J (1994) Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. J Urol 151:1078-1080